15 July 2003
STRONG RESULTS IN Q2 CONTINUE GROWTH TREND
The following is the text for the Reckitt Benckiser conference call to be given
today by Bart Becht, Chief Executive Officer, and Colin Day, Chief Financial
Officer, at 1430 hrs London time. The purpose of the call is to update the
market on progress of the business in the second quarter of 2003.
Commenting on the position, Bart Becht said
'Q2 will be a strong quarter for both net revenues and profits for Reckitt
Benckiser. Net revenue growth at 7% was above the full year target and came
from practically all categories and regions.
'The Company's net revenue growth in Western Europe was particularly good
behind new product initiatives resulting in strong profit growth. Net revenues
in North America were in line with last year as market growth slowed to zero
and that, combined with higher marketing investment, resulted in lower profits
for the quarter. However activities for the second half have already been
adjusted with the aim of re-establishing profitable growth in North America.
Reckitt Benckiser's recovery in the emerging markets of Asia and Rest of World
accelerated.
'Net, after two strong quarters, Reckitt Benckiser is firmly on track to
deliver on the Company's full year targets.'
Update on Q2.
For the total Company, net revenue growth at constant exchange in the second
quarter is expected to be around 7% (2002 base £901m). The exchange rate impact
on net revenues in Q2 was less than 1% resulting in net revenue growth also at
close to 7% at actual exchange.
Profitability benefited from further improvement in gross margins, driven by
product mix and by savings from c ost optimiz ation program s. Operating margin
expansion reflected the heavy phasing of marketing investment behind new
initiatives in Q2. Cash generation was strong. Consequently, the Company looks
for the Q2 normalized net income growth rate to be in line with the full year
target (2002 base of £103m).
Half Year
This will bring net revenue growth for the half year to over 6% at constant
exchange. Exchange rates were adverse in the half year overall, reducing the
over 6% constant exchange rate growth by 2% points at actual exchange to over
4% (2002 Base £1,756m). Profitability has improved, due to strong gross margin
expansion somewhat offset by the substantial phasing of marketing investment
into the first half of the year, resulting in operating margin expansion in
line with the Company's long-term objectives. Net income growth for the half
year is expected to be somewhat ahead of the target full year growth (2002 base
of £173m).
Full Year Targets
The full year target growth rate for net revenues is 4% to 6% and for net
income of low double digits, both at constant exchange.
The full results for Q2 and Half Year 2002 will be released on 26th August
2003.
For Further Information
Tom Corran telephone +44 (0) 1753 217 800
SVP Investor Relations & Corporate Communications
Mark Wilson telephone +44 (0) 1753 217 800
Investor Relations Manager
Tim Spratt telephone +44 (0) 207 831 3113
Financial Dynamics
Notes.
Discontinued business
Discontinued business in 2002 relates to: -
1. The results of the Group's subsidiary in Zimbabwe which have been excluded
from the consolidated Group results with effect from 1st July 2002. The effect
of this is that net revenues of £7m in Q2 and £13m in the first half of 2002
will be shown as discontinued and de-consolidated. The resulting profit impact
in H1 2002 was £1m.
2. An agency agreement under which the Group sold third party products in one
category in one European market (Bayer pest control products in Italy) was
terminated with effect from the end of 2002. This will be shown as discontinued
in the half year and full year results. The impact will be to reclassify
operating profit by £1m in H1 2002 and £2m in FY 2002 into discontinued
business. No income was recorded in 2003. Net revenues for this agency business
were not recognized.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.